Adverum Biotechnologies
ADVM
$8.04
Share price
-2.55%
Change (1 day)
957.89%
Change (1 year)
P/S ratio for Adverum Biotechnologies (ADVM)
P/S ratio as of May 2024 (TTM): 47.6
According to Adverum Biotechnologies 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 47.5677. At the end of 2023 the company had a P/S ratio of 21.1.
P/S ratio history for Adverum Biotechnologies from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 21.1 | |
| 2022 | N/A | -100% |
| 2021 | 23.0 | |
| 2020 | N/A | -100% |
| 2019 | > 1000 | 2421.54% |
| 2018 | 123 | 44.31% |
| 2017 | 85.3 | 2.54% |
| 2016 | 83.2 | -21.67% |
| 2015 | 106 | -95.06% |
| 2014 | > 1000 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |